Pharmacology, Toxicology and Pharmaceutical Science
Absence
6%
Adverse Event
13%
Antimalarial Activity
5%
Antimalarial Agent
61%
Artemether Plus Benflumetol
22%
Artemisinin
45%
Artemisinin Derivative
7%
Artesunate
15%
Chloroquine
30%
Cholera
7%
Cholera Vaccine
9%
Clinical Trial
10%
Cohort Study
10%
Combination Therapy
17%
Dihydroartemisinin
24%
Diseases
7%
Drug
34%
Drug Resistance
13%
Elimination
14%
Fever
10%
Glucose 6 Phosphate Dehydrogenase
62%
Glucose 6 Phosphate Dehydrogenase Deficiency
19%
Hemoglobin
12%
Hemolysis
15%
IC50
5%
Incidence
21%
Infection
22%
Malaria
100%
Malaria Falciparum
52%
Mefloquine
7%
Parasite
13%
Parasite Clearance
6%
Parasitemia
19%
Piperaquine
18%
Placebo
9%
Plasmodium falciparum
34%
Plasmodium vivax
43%
Plasmodium Vivax Malaria
69%
Prevalence
16%
Primaquine
82%
Pyrimethamine Plus Sulfadoxine
7%
Quinine
7%
Randomized Controlled Trial
6%
Recurrent Disease
26%
Salmonella
6%
Salmonella Enterica Serovar Typhi
7%
Salmonellosis
5%
Symptom
8%
Typhoid Fever
14%
Vaccine
9%
Medicine and Dentistry
Analysis
26%
Antimalarial Agent
16%
Antimalarial Drug Resistance
16%
Arm
11%
Artemisinin
31%
Assessment
20%
Blood Culture
11%
Chemotherapeutic Agent
9%
Child
17%
Chloroquine
28%
Cholera
12%
Cholera Vaccine
9%
Clinical Study
10%
Clinical Trial
9%
Cohort Analysis
9%
Combination Therapy
18%
Diagnosis
28%
Diseases
11%
Evaluation Study
17%
Fever
13%
Follow up
11%
Genotype
12%
Glucose 6 Phosphate Dehydrogenase
27%
Health
17%
Health Care Cost
13%
Hospital
9%
Household
9%
Incidence
20%
Infection
15%
Introspection
9%
Malaria
63%
Malaria Falciparum
35%
Meta-Analysis
33%
Parasite (Microbiology)
16%
Parasite Clearance
11%
Parasitemia
17%
Patient
50%
Plasmodium
60%
Plasmodium Vivax Malaria
35%
Pregnancy
16%
Primaquine
27%
Rapid Diagnostic Test
14%
Recrudescence
9%
Salmonella
16%
Serotype
11%
Surveillance
17%
Therapeutic Procedure
79%
Typhoid Fever
36%
Vaccine
12%
Woman
10%
Nursing and Health Professions
Analysis
17%
Antimalarial Agent
5%
Artemether Plus Benflumetol
5%
Blood Culture
7%
Bloodstream Infection
5%
Combination Therapy
5%
Control
7%
Culture
6%
Diagnosis
38%
Diagnostic Test
15%
Disease Burden
5%
Diseases
10%
Evaluation Study
12%
Glucose 6 Phosphate Dehydrogenase
30%
Glucose 6 Phosphate Dehydrogenase Deficiency
6%
Infection
5%
Malaria
62%
Malaria Control
5%
Malaria Falciparum
6%
Measurement
6%
Meta Analysis
14%
Patient
24%
Plasmodium Vivax Malaria
31%
Practice Guideline
10%
Primaquine
16%
Procedures
7%
Resident
6%
Sample
12%
Sensitivity and Specificity
5%
Spectrophotometry
5%
Systematic Review
10%
Typhoid Fever
22%
Woman
6%
World Health Organization
6%